| 000 | 01800 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513120705.0 | ||
| 264 | 0 | _c19970627 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm970038v _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMichaelides, M R | |
| 245 | 0 | 0 |
_aSubstituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cMay 1997 |
||
| 300 |
_a1585-99 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenylyl Cyclases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzazepines _xmetabolism |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 |
_aCorpus Striatum _xmetabolism |
| 650 | 0 | 4 |
_aDopamine Agonists _xchemical synthesis |
| 650 | 0 | 4 |
_aDopamine Antagonists _xmetabolism |
| 650 | 0 | 4 | _aFishes |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aOxidopamine |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 |
_aQuinolones _xchemical synthesis |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
| 650 | 0 | 4 |
_aRetina _xenzymology |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aThiophenes _xchemical synthesis |
| 650 | 0 | 4 | _aTritium |
| 650 | 0 | 4 |
_aYohimbine _xmetabolism |
| 700 | 1 | _aHong, Y | |
| 700 | 1 | _aDiDomenico, S | |
| 700 | 1 | _aBayburt, E K | |
| 700 | 1 | _aAsin, K E | |
| 700 | 1 | _aBritton, D R | |
| 700 | 1 | _aLin, C W | |
| 700 | 1 | _aShiosaki, K | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 40 _gno. 11 _gp. 1585-99 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm970038v _zAvailable from publisher's website |
| 999 |
_c9152988 _d9152988 |
||